Valuation
Search documents
Celsius Holdings Stock Before Q1 Earnings: To Buy or Not to Buy?
ZACKS· 2025-05-02 13:30
Celsius Holdings, Inc. (CELH) is likely to register a top and bottom-line decline when it reports first-quarter 2025 earnings on May 6.The Zacks Consensus Estimate for revenues is pegged at $341.7 million, which indicates almost a 4% decrease from the year-ago period's level.Although the consensus mark for quarterly earnings has moved up a penny in the past 30 days to 20 cents per share, the projection indicates a 25.9% decrease from the year-ago quarter’s figure. CELH has a trailing four-quarter negative e ...
Buy, Sell or Hold F Stock? Key Insights Ahead of Q1 Earnings
ZACKS· 2025-05-01 15:00
Core Viewpoint - Ford is expected to report breakeven EPS and automotive revenues of $35.5 billion for Q1 2025, reflecting an 11% decline from the previous year [1][3]. Financial Estimates - The Zacks Consensus Estimate for Ford's full-year automotive revenues in 2025 is $162.3 billion, indicating a 6% year-over-year decline [3]. - The consensus estimate for full-year EPS is $1.22, representing a 33.7% contraction compared to the previous year [3]. - In the trailing four quarters, Ford surpassed EPS estimates twice, missed once, and matched once, with an average earnings surprise of 1.21% [3]. Sales Performance - Ford's sales volume for Q1 2025 is projected to decline by 1.3% to 501,291 units, attributed to rental fleet sales timing and the discontinuation of certain models [5]. - Retail sales increased by 5% during the quarter, while sales of electrified vehicles surged by 25.5% to 73,623 units [5]. Segment Revenue Estimates - The Zacks Consensus Estimate for revenues from the Ford Blue unit is $17.6 billion, down 19% year-over-year, with EBIT expected to drop from $905 million to $275 million [8]. - Revenues from the Ford model e unit are estimated at $1.5 billion, a significant increase from $115 million in the same period last year, with a projected loss before interest and taxes of $1.17 billion [9]. - The Ford Pro unit's revenues are expected to be $16.2 billion, reflecting a 10% decline year-over-year, with EBIT anticipated to decrease from $3 billion to $1.5 billion [10]. Market Performance - Year-to-date, Ford's shares have increased by 1.1%, outperforming both Tesla and General Motors, whose shares have dropped by 30% and 15%, respectively [11]. - Ford is trading at a forward price/sales ratio of 0.24, significantly lower than the industry average of 2.37, indicating a relatively cheap valuation [14]. Future Outlook - Ford's 2025 outlook is cautious, with full-year adjusted EBIT forecasted at $7-$8.5 billion, down from $10.2 billion in 2024, influenced by warranty costs and incentives [18]. - Despite challenges, the Ford Pro segment is expected to be a major profit driver, supported by strong order books and demand signals [19]. - Ford maintains a high dividend yield of approximately 6%, targeting a payout ratio of 40-50% of free cash flow, which is attractive to income-focused investors [19].
Devon Energy vs. Occidental: Which Energy Stock Has More Growth Ahead?
ZACKS· 2025-04-30 16:50
Industry Overview - The oil and gas industry is crucial for the global economy, providing primary energy sources for various sectors including transportation and manufacturing [1] - Despite the shift towards renewable energy, oil and gas remain essential due to their high energy density and established infrastructure [1] Devon Energy Corporation (DVN) - Devon Energy is a leading independent oil and natural gas exploration and production company in the U.S., focusing on high-quality assets and strategic acquisitions to enhance production [2] - The company has been managing costs effectively by selling higher-cost assets and bringing lower-cost production assets online [2] - Devon's earnings estimates indicate a year-over-year decline of 5.81% for 2025, with a slight growth of 1.1% expected in 2026 [5] - Current dividend yield for Devon Energy is 3.07%, with 11 dividend increases in the past five years [20] - Devon Energy's debt to capital ratio is 36.35%, indicating a lower reliance on debt compared to its peers [14] - The company plans to invest between $3.8 billion and $4 billion in 2025, following a $3.64 billion investment in 2024 [18] Occidental Petroleum Corporation (OXY) - Occidental Petroleum operates across upstream exploration, midstream logistics, and chemical manufacturing, focusing on strong hydrocarbon volumes [3] - The company's earnings estimates suggest a significant year-over-year decline of 26.01% for 2025, with a recovery of 19.42% expected in 2026 [9] - Current dividend yield for Occidental Petroleum is 2.38%, with five dividend increases in the past five years [20] - Occidental's debt to capital ratio stands at 42.01%, indicating a higher reliance on debt compared to Devon [14] - The company plans to invest between $7.4 billion and $7.6 billion in 2025, following over $7 billion in investments to strengthen operations [19] Comparative Analysis - Devon Energy has a higher return on equity (ROE) of 22.52% compared to Occidental's 16.33%, both exceeding the sector average of 15.44% [11] - Devon Energy is trading at a lower EV/EBITDA ratio of 3.76X compared to Occidental's 5.09X, while the sector average is 4.38X [15] - In the past three months, Devon Energy shares declined by 11.1%, while Occidental's shares fell by 15.8% [22] - Devon Energy's strategic focus on multi-basin domestic assets provides a competitive edge, helping to mitigate geopolitical and regulatory risks faced by Occidental [24][25]
Is Most-Watched Stock Gilead Sciences, Inc. (GILD) Worth Betting on Now?
ZACKS· 2025-04-30 14:06
Core Viewpoint - Gilead Sciences has experienced a decline in stock performance recently, and various factors, including earnings estimates and revenue growth, will influence its future stock trajectory [2][5][11]. Earnings Estimate Revisions - Gilead is projected to report earnings of $1.99 per share for the current quarter, reflecting a year-over-year decrease of 1% [5]. - The consensus earnings estimate for the current fiscal year is $7.91, indicating a significant year-over-year increase of 71.2% [5]. - For the next fiscal year, the consensus estimate is $8.39, representing a year-over-year growth of 6.1% [6]. - The Zacks Rank for Gilead is 3 (Hold), indicating a neutral outlook based on recent earnings estimate revisions [7]. Revenue Growth Forecast - The consensus sales estimate for Gilead in the current quarter is $7 billion, showing a year-over-year increase of 0.6% [11]. - Revenue estimates for the current and next fiscal years are $28.51 billion (a decrease of 0.8%) and $29.78 billion (an increase of 4.5%), respectively [11]. Last Reported Results and Surprise History - Gilead reported revenues of $6.67 billion in the last quarter, which is a year-over-year decline of 0.3% [12]. - The EPS for the last reported quarter was $1.81, compared to -$1.32 a year ago, with a revenue surprise of -2.46% and an EPS surprise of -0.55% [12]. - Over the last four quarters, Gilead has surpassed consensus EPS estimates three times and revenue estimates three times [13]. Valuation - Gilead's valuation metrics, including price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), are essential for assessing whether the stock is fairly valued [14][15]. - The Zacks Value Style Score for Gilead is graded B, indicating that the stock is trading at a discount compared to its peers [17].
Anheuser-Busch InBev Q1 Preview: A Steady Transformation Worth Watching
Seeking Alpha· 2025-04-30 13:16
Group 1 - Anheuser-Busch InBev SA/NV (BUD) is set to report earnings on May 8, with significant changes in operational conditions expected [1] - The upcoming earnings report will provide insights beyond just quarterly numbers, indicating a shift in the company's operational landscape [1] Group 2 - The company is under scrutiny for its performance metrics and competitive positioning in the market [1]
Billionaire Bill Ackman Has 12% of His Pershing Square Portfolio Invested in 1 Stock That's Down 17% in 2025: Time to Buy?
The Motley Fool· 2025-04-30 01:00
Core Viewpoint - Bill Ackman, a prominent investor, focuses on concentrated investments in high-quality businesses, with his hedge fund, Pershing Square Capital Management, having a strong track record over the past two decades [1] Company Overview - As of December 31, Pershing Square held 11 positions, with one company representing 12% of the fund, making it the third-largest holding despite Ackman selling shares over several quarters [2] - Chipotle Mexican Grill (CMG) has shown significant stock performance, with shares increasing by 183% over the past five years, although they have declined by 17% in 2025 [2][8] Financial Performance - Chipotle has consistently generated positive free cash flow (FCF), reporting a cumulative FCF of $3.6 billion from 2021 to 2024, which has been partly used for share buybacks [3] - The company maintains a strong balance sheet, with more current assets than liabilities and no debt, allowing it to earn interest income rather than incur interest expenses [4] Competitive Position - Ackman values high barriers to entry in the restaurant industry, noting that while competition is fierce, replicating Chipotle's success is extremely challenging [5] Investment Strategy - Ackman sold approximately 17 million shares of Chipotle in 2024, likely due to high valuation rather than company quality, as the stock traded at an average forward P/E ratio of 51.2 [6][7] - Despite the sales, Pershing Square retained a significant position in Chipotle, indicating continued bullish sentiment, especially with the stock down 27% from its all-time high [8] Market Conditions - Chipotle experienced a 0.4% decline in same-store sales in Q1, attributed to weaker consumer spending, though the leadership remains optimistic about the company's long-term potential [9] - The stock is currently trading at a more reasonable forward P/E ratio of 41.3, suggesting a potential opportunity for investors to consider dollar-cost averaging into Chipotle shares [10]
Should You Buy Mastercard Before Q1 Earnings? Key Estimates to Note
ZACKS· 2025-04-29 17:06
Core Viewpoint - Mastercard is expected to report first-quarter 2025 results on May 1, 2025, with earnings estimated at $7.57 per share and revenues of $7.13 billion, reflecting a year-over-year earnings increase of 7.9% and revenue growth of 12.3% [1][2] Financial Estimates - The Zacks Consensus Estimate for Mastercard's total revenues in 2025 is $31.59 billion, indicating a year-over-year rise of 12.2% [2] - The consensus estimate for 2025 earnings per share is $15.89, suggesting an increase of approximately 8.8% year-over-year [2] Earnings Performance History - Mastercard has a strong track record of exceeding earnings estimates, having beaten the consensus in each of the last four quarters with an average surprise of 3.3% [3] Earnings Prediction Model - Current indicators do not strongly predict an earnings beat for the upcoming quarter, with an Earnings ESP of -0.05% and a Zacks Rank of 3 (Hold) [4] Key Growth Drivers - The Gross Dollar Volume (GDV) for Mastercard is projected to rise by 8.1% year-over-year, with domestic operations expected to grow by nearly 7% and international operations by 8% [6] - Switched transactions are anticipated to increase by 9.9% year-over-year, driven by resilient consumer spending and enhanced contactless payment initiatives [7] - Cross-border volumes are expected to grow by 14%, with domestic assessments and transaction processing assessments projected to rise by 8.4% and 8.9%, respectively [8] Value-added Services - The Zacks Consensus Estimate for net revenues from Value-added Services and Solutions indicates a 17% year-over-year growth, supported by demand for consulting, marketing services, and loyalty solutions [9] Expense Considerations - Rising expenses, including a projected 13.7% increase in adjusted operating costs and a 10.6% rise in payments network rebates and incentives, may offset growth potential [11] Stock Performance - Mastercard's stock has gained 1.5% year-to-date, outperforming the industry decline of 0.9%, while Visa has increased by 6.8% and American Express has decreased by 10.7% [12] Valuation Metrics - Mastercard is currently trading at a forward P/E of 31.85X, above its five-year median of 31.82X and the industry average of 22.31X, indicating a stretched valuation [16] - In comparison, Visa and American Express are trading at forward P/Es of 27.84X and 16.63X, respectively [17] Strategic Outlook - Despite strong fundamentals and growth potential, the high valuation relative to industry averages raises concerns, particularly in light of rising macroeconomic risks and competitive pressures in the digital payments landscape [18][19]
Should You Stick With Chevron Before Its Q1 Earnings Drop?
ZACKS· 2025-04-29 14:31
Image Source: Zacks Energy supermajor Chevron Corporation (CVX) is slated to release its first-quarter 2025 results on May 2, before market open. The Zacks Consensus Estimate for the to-be-reported quarter's earnings per share (EPS) and revenues is pegged at $2.30 per share and $47.9 billion, respectively. The earnings estimates for the to-be-reported quarter have been revised downward by 7.6% over the past 30 days. The bottom-line projection indicates a decline of 21.5% from the year-ago reported number. T ...
Can Sustained Product Demand Drive BDX Stock Before Q2 Earnings?
ZACKS· 2025-04-28 17:20
Core Viewpoint - Becton Dickinson and Company (BDX) is set to report its second-quarter fiscal 2025 results, with expectations of revenue growth driven by advancements in its medical segments and product adoption, despite some challenges in the market [1][11]. Group 1: BD Medical Segment - The BD Medical segment is expected to see significant revenue growth, with estimates of $2.85 billion, reflecting a 16.3% year-over-year increase, aided by the adoption of the BD PIVO Pro Needle-free Blood Collection Device [4][2]. - Management has made progress in the Connected Care strategy and received FDA clearance for new monitoring devices, which is likely to enhance revenue in this segment [3]. Group 2: BD Life Sciences Segment - The BD Life Sciences segment's revenues are estimated at $1.29 billion, a slight decline of 1.3% year-over-year, influenced by the expansion of fingertip blood testing and the success of the BD Onclarity HPV Assay [7][6]. - The segment is advancing in the high-volume molecular testing market, which is expected to contribute positively to revenues [6]. Group 3: BD Interventional Segment - The BD Interventional segment is projected to generate $1.33 billion in revenue, up 2.8% year-over-year, supported by ongoing product adoption and new applications in advanced tissue regeneration [10][9]. - The segment has received EU approval for new products, which is expected to drive further growth [8]. Group 4: Overall Financial Estimates - The overall revenue consensus estimate for the second quarter is $5.37 billion, indicating a 6.4% increase from the previous year, with EPS expected to rise by 3.5% to $3.28 [11]. Group 5: Valuation and Market Performance - BD's forward 12-month price-to-earnings (P/E) ratio is 13.6X, which is below the industry average of 16.6X, suggesting a potential undervaluation relative to peers [20][21]. - Over the past three months, BD's shares have declined by 16.3%, underperforming both the medical supplies sector and the broader market [14][18]. Group 6: Long-Term Prospects - The company is investing in its U.S. manufacturing network to enhance capacity for critical medical devices, which is expected to benefit the Medication Delivery Solutions business in the long term [22]. - BD's collaboration with Biosero aims to enhance drug discovery processes, indicating a commitment to innovation and growth in the Life Sciences segment [23].
UPS Gears Up to Report Q1 Earnings: How to Play the Stock
ZACKS· 2025-04-25 15:55
Core Viewpoint - United Parcel Service (UPS) is expected to report a decline in both earnings and revenues for the first quarter of 2025, with earnings estimated at $1.42 per share, a 0.7% decrease from the previous year, and revenues projected at $21.06 billion, indicating a 3% decline from the same quarter last year [1][2]. Earnings and Revenue Estimates - The Zacks Consensus Estimate for UPS's earnings is $1.42 per share, reflecting a downward revision of seven cents over the past 60 days [1]. - Revenue estimates stand at $21.06 billion, which is a 3% decline compared to the year-ago quarter [2]. Earnings Surprise History - UPS has a history of earnings surprises, with an average surprise of 3.43% across the last four quarters [3]. Earnings Prediction Model - The current Earnings ESP for UPS is -4.08%, indicating a lower likelihood of an earnings beat this quarter [5][6]. - UPS holds a Zacks Rank of 4 (Sell), suggesting a bearish outlook [6]. Factors Influencing Q1 Results - Geopolitical uncertainties and high inflation are expected to negatively impact shipping volumes [7]. - Labor costs are anticipated to be high, while low fuel costs may provide some relief, with a projected 5.1% decrease in fuel expenses compared to Q1 2024 [8]. Stock Performance - UPS stock has declined by 32.9% over the past year, underperforming its industry, which saw a 29.7% decline, while the S&P 500 rose by 7% [10]. Valuation Metrics - UPS is trading at a forward sales multiple of 0.96, which is higher than its industry peers, indicating a stretched valuation [13]. Investment Thesis - A decline in shipping demand is expected, with average daily volumes projected to decrease by 8.5% in 2025 compared to 2024 [16]. - Recent easing signals in the U.S.-China trade tensions may provide some optimism, but concerns over dividend sustainability amid demand weakness remain [18]. Long-term Outlook - Despite near-term challenges, UPS's strong brand and network position it as a compelling long-term investment in the transportation sector [19].